arcoris bio is a biotechnology company founded in 2022 with the mission to enable precise diagnosis and personalized treatment through multiplex biomarkers. The company develops accessible and high-performance solutions for researchers and clinicians. Its proprietary MUSE technology addresses key challenges in multiplex detection by delivering high sensitivity and specificity.

Betta Scientific is a specialized consultancy and scientific services company with deep expertise in translating scientific innovation into commercial success. With its experienced team, Betta Scientific supports organizations in developing market strategies, scaling sales and building international distribution frameworks.

Today, arcoris bio and Betta Scientific announce a strategic collaboration to accelerate arcoris bio’s global commercial expansion and strengthen its business-to-customer (B2C) capabilities.

Under this collaboration, Betta Scientific will support the development and execution of arcoris bio’s global market strategy, with a focus on establishing and expanding distribution networks across Europe, Asia-Pacific (APAC), and the Americas. This will enable arcoris bio to scale its commercial reach and improve product accessibility for customers worldwide.

By combining arcoris bio’s proprietary technology with Betta Scientific’s commercial expertise, the collaboration is positioned to accelerate international growth and broaden access to advanced multiplex biomarker solutions.

Both companies look forward to a successful partnership and to advancing global access to innovative biotech solutions.